F. Doni

Type II Atrial Flutter Interruption with Transesophageal Pacing: Use of Propafenone and Possible Change of the Substrate

C. Fiorentini, A. Rimondini, F. Doni, 1996, Pacing and clinical electrophysiology : PACE.

Effects of disopyramide on cycle length, effective refractory period and excitable gap of atrial flutter, and relation to arrhythmia termination by overdrive pacing.

C. Tondo, G. Marenzi, P. Della Bella, 1989, The American journal of cardiology.

New onset atrial flutter termination by overdrive transoesophageal pacing: effects of different protocols of stimulation.

C. Fiorentini, A. Rimondini, F. Doni, 2000, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

Carboplatin-induced Kounis syndrome.

M. Baroni, F. Doni, Sarah P. Todd, 2011, Journal of cardiology cases.

Quinidine for Pharmacological Cardioversion of Long-lasting Atrial Fibrillation.

A. Kheir, M. Baroni, F. Doni, 2011, Journal of atrial fibrillation.

Atrial flutter termination by overdrive transesophageal pacing and the facilitating effect of oral propafenone.

C. Fiorentini, A. Rimondini, P. Della Bella, 1995, The American journal of cardiology.

Facilitating influence of disopyramide on atrial flutter termination by overdrive pacing.

C. Cipolla, C. Tondo, G. Marenzi, 1988, The American journal of cardiology.